Rx INDUSTRY NEEDS TO PREPARE TO DEFEND DTC AD BUDGETS, AAAA's KAMP TELLS FDLI; FDA DTC POLICY REQUIRES "SERIOUS" ENFORCEMENT BY AGENCY -- FDA'S SCHULTZ
Executive Summary
Pharmaceutical companies need to prepare to defend their direct-to-consumer ad budgets from political attacks, American Association of Advertising Agencies Senior VP John Kamp told the Food & Drug Law Institute Sept. 3 in Washington, D.C.